Dezima Pharma (‘Dezima’), the biotechnology company developing innovative drugs in the field of dyslipidemia, announced today that it has appointed Rob de Ree as its new Chief Executive Officer.
Dezima Pharma (‘Dezima’), the biotechnology company developing innovative drugs in the field of dyslipidemia, announced today that it has appointed Rob de Ree as its new Chief Executive Officer.